Contrast-enhanced ultrasound for abdominal image-guided procedures.
Abdominal
CEUS
Contrast-enhanced
Image-guided procedures
Percutaneous
Ultrasound
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
medline:
21
4
2023
pubmed:
1
3
2023
entrez:
28
2
2023
Statut:
ppublish
Résumé
Since FDA approval for contrast-enhanced ultrasound (CEUS), clinical applications have increased to include diagnostic imaging of hepatic, renal, and other abdominal lesions. The modality has also demonstrated utility in certain image-guided procedures. Intravascular ultrasound contrast agents use microbubbles to improve visibility of solid tumors. Lesions not well seen on grayscale or Doppler ultrasound may become amenable to CEUS-guided biopsy or ablation. This pictorial essay provides eleven examples to illustrate the current use of CEUS in a variety of abdominal image-guided procedures. Hepatic, renal, peritoneal, and soft tissue cases are presented. CEUS can improve visualization and targeting in abdominal image-guided procedures, without nephrotoxicity or radiation exposure.
Identifiants
pubmed: 36853392
doi: 10.1007/s00261-023-03804-5
pii: 10.1007/s00261-023-03804-5
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1438-1453Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Investigative Radiology 3(5): 356–366. doi: https://doi.org/10.1097/00004424-196809000-00011
doi: 10.1097/00004424-196809000-00011
pubmed: 5688346
Brannigan M, Burns PN, Wilson SR (2004) Blood flow patterns in focal liver lesions at microbubble-enhanced US. RadioGraphics 24(4):921–935. https://doi.org/ https://doi.org/10.1148/rg.244035158
doi: 10.1148/rg.244035158
pubmed: 15256618
Gulati M, King KG, Gill IS, Pham V, Grant E, Duddalwar VA (2015) Contrast-enhanced ultrasound (CEUS) of cystic and solid renal lesions: a review. Abdom Imaging 40(6):1982–1996. https://doi.org/ https://doi.org/10.1007/s00261-015-0348-5
doi: 10.1007/s00261-015-0348-5
pubmed: 25588715
Dietrich CF, Averkiou M, Nielsen MB et al. (2017) How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open 4(1):E2–E15. https://doi.org/ https://doi.org/10.1055/s-0043-123931
doi: 10.1055/s-0043-123931
Lorentzen T, Nolsoe CP (2019) The role of US contrast agents in US-guided biopsy of focal liver lesions: a pictorial review. Ultrasound Int Open 5(1):E11–E19. https://doi.org/ https://doi.org/10.1055/a-0770-4237
doi: 10.1055/a-0770-4237
pubmed: 30599041
Huang DY, Yusuf GT, Daneshi M, Ramnarine R, Deganello A, Sellars ME, Sidhu PS (2018) Contrast-enhanced ultrasound (CEUS) in abdominal intervention. Abdom Radiol 43:960–976. https://doi.org/ https://doi.org/10.1007/s00261-018-1473-8
doi: 10.1007/s00261-018-1473-8
Lorentzen T, Nolsøe C, Ewertsen C et al. (2015) EFSUMB guidelines on interventional ultrasound (INVUS), part I – general aspects (long version). Ultraschall Med 36(05): E1–E14. DOI: https://doi.org/10.1055/s-0035-1553593
doi: 10.1055/s-0035-1553593
pubmed: 26468774
Sidhu PS, Brabrand K, Cantisani V et al. (2015) EFSUMB guidelines on interventional ultrasound (INVUS), part II – diagnostic ultrasound-guided interventional procedures (long version). Ultraschall Med 36(06): E15–E35. DOI: https://doi.org/10.1055/s-0035-1554036
doi: 10.1055/s-0035-1554036
pubmed: 26669871
Burak KW, Sherman M (2015) Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting. Can J Gastroenterol Hepatol. 29(4):178–84. doi: https://doi.org/10.1155/2015/824263
doi: 10.1155/2015/824263
pubmed: 25965437
pmcid: 4444026
Omata M, Lesmana LA, Tateishi R et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 18;4(2):439–74. doi: https://doi.org/10.1007/s12072-010-9165-7
Chen C, Liang P, Yu J, Yu X, Cheng Z, Han Z, Liu F, Li X (2016) Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound. International Journal of Hyperthermia, 32:6, 607–613, DOI: https://doi.org/10.3109/02656736.2016.1172118
doi: 10.3109/02656736.2016.1172118
pubmed: 27269816
Emanuel AL, Meijer RI, Van Poelgeest E, Spoor P, Serné EH, Eringa EC (2020) Contrast-enhanced ultrasound for quantification of tissue perfusion in humans. Microcirculation 27(1):e12588. doi: https://doi.org/10.1111/micc.12588
doi: 10.1111/micc.12588
pubmed: 31465606
Shakeri S, Afshari Mirak S, Mohammadian Bajgiran A et al. (2019) The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas. Abdom Radiol 44, 2308–2315. https://doi.org/ https://doi.org/10.1007/s00261-019-01967-8
doi: 10.1007/s00261-019-01967-8
Jenssen C, Hocke M, Fusaroli P et al. (2015) EFSUMB guidelines on interventional ultrasound (INVUS), Part IV – EUS-guided interventions: General aspects and EUS-guided sampling (long version). Ultraschall Med 37(02): E33–E76. DOI: https://doi.org/10.1055/s-0035-1553785
doi: 10.1055/s-0035-1553785
pubmed: 26515966
Piscaglia F, Nolsøe C, Dietrich CF et al. (2011) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): Update 2011 on non-hepatic applications. Ultraschall Med 33(1): 33–59. DOI: https://doi.org/10.1055/s-0031-1281676
doi: 10.1055/s-0031-1281676
pubmed: 21874631
Eisenbrey JR, Sridharan A, Machado P et al. (2012) 3D subharmonic ultrasound imaging in vitro and in vivo. Acad Radiol. 19(6): 732–739. https://doi.org/ https://doi.org/10.1016/j.acra.2012.02.015
doi: 10.1016/j.acra.2012.02.015
pubmed: 22464198
pmcid: 3351552
Bracco Diagnostic, Inc. (2022) Lumason datasheet. https://imaging.bracco.com/us-en/products/contrast-enhanced-ultrasound/lumason . Accessed 26 February 2022
General Electric Healthcare (2022) Optison datasheet. https://www.gehealthcare.com/products/contrast-media/optison . Accessed 26 February 2022
Lantheus Medical Imaging, Inc. (2022) Definity datasheet. https://www.lantheus.com/products/overview/definity-3/ . Accessed 26 February 2022
Claudon M, Dietrich CF, Choi BI et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 34:11–29. https://doi.org/ https://doi.org/10.1055/s-0032-1325499
doi: 10.1055/s-0032-1325499
pubmed: 23129518
Lindner JR, Belcik T, Main ML et al. (2021) Expert Consensus Statement from the American Society of Echocardiography on Hypersensitivity Reactions to Ultrasound Enhancing Agents in Patients with Allergy to Polyethylene Glycol (PEG). American Society of Echocardiography, April 2021. https://www.asecho.org/wp-content/uploads/2021/05/ASE-2526_FDA-EDC-Document_p5.pdf . Accessed 17 May 2022
Dietrich CF, Nolsøe CP, Barr RG et al. (2020) Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol. 46(10):2579–2604. doi: https://doi.org/10.1016/j.ultrasmedbio.2020.04.030
doi: 10.1016/j.ultrasmedbio.2020.04.030
pubmed: 32713788
D’Onofrio M, Crosara S, De Robertis R, Canestrini S, Mucelli RP (2015) Contrast-enhanced ultrasound of focal liver lesions. Am J Roentgenol 205:W56–W66. https://doi.org/ https://doi.org/10.2214/ajr.14.14203
doi: 10.2214/ajr.14.14203
Yoon SH, Lee KH, Kim SY, Kim YH, Kim JH, Lee SH, Kim TK (2010) Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. Eur Radiol 20:2047–2056. https://doi.org/ https://doi.org/10.1007/s00330-010-1757-z
doi: 10.1007/s00330-010-1757-z
pubmed: 20309559
Francica G, De Sio I, Meloni MF et al. (2018) Biopsy of liver target lesions under contrast-enhanced ultrasound guidance. A multicenter study. Ultraschall Med. 39(4): 448–453. doi: https://doi.org/10.1055/s-0043-122496 .
doi: 10.1055/s-0043-122496
pubmed: 29232723
Lekht I, Gulati M, Nayyar M, Katz MD, Ter-Oganesyan R, Marx M, Cen SY, Grant E (2016) Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone. Abdom Radiol 41(8):1511–1521. https://doi.org/ https://doi.org/10.1007/s00261-016-0700-4
doi: 10.1007/s00261-016-0700-4
Catalano O, Sandomenico F, Raso MM, Siani A (2005) Real-time, contrast-enhanced sonography: a new tool for detecting active bleeding. J Trauma 59(4):933–939 doi: https://doi.org/10.1097/01.ta.0000188129.91271.ab
doi: 10.1097/01.ta.0000188129.91271.ab
pubmed: 16374284
Tagliati C, Argalia G, Polonara G et al. (2019) Contrast-enhanced ultrasound in delayed splenic vascular injury and active extravasation diagnosis. Radiol Med 124:170–175 https://doi.org/ https://doi.org/10.1007/s11547-018-0961-9
doi: 10.1007/s11547-018-0961-9
pubmed: 30488252
Rafailidis V, Fang C, Yusuf GT et al. (2018) Contrast-enhanced ultrasound (CEUS) of the abdominal vasculature. Abdom Radiol 43, 934–947. https://doi.org/ https://doi.org/10.1007/s00261-017-1329-7
doi: 10.1007/s00261-017-1329-7
Helck A. Hoffmann RT, Sommer WH et al. (2010) Diagnosis, therapy monitoring and follow up of renal artery pseudoaneurysm with contrast-enhanced ultrasound in three cases.” Clinical Hemorheology and Microcirculation 46(2–3):127–137. DOI: https://doi.org/10.3233/CH-2010-1339
doi: 10.3233/CH-2010-1339
pubmed: 21135488